Sedative, hypnotic or anxiolytic abuse with withdrawal delirium
ICD-10 F13.131 is a billable code used to indicate a diagnosis of sedative, hypnotic or anxiolytic abuse with withdrawal delirium.
F13.131 refers to the abuse of sedative, hypnotic, or anxiolytic substances, which can lead to significant psychological and physiological dependence. This condition is characterized by a pattern of use that results in clinically significant impairment or distress, including withdrawal symptoms upon cessation. Withdrawal delirium, a severe form of withdrawal, is marked by confusion, agitation, hallucinations, and autonomic instability. Patients may experience tremors, sweating, and increased heart rate, which can escalate to life-threatening complications if not managed appropriately. Treatment typically involves a combination of pharmacological interventions to manage withdrawal symptoms and psychological support to address the underlying substance use disorder. Comprehensive treatment programs may include detoxification, counseling, and long-term rehabilitation strategies to prevent relapse and promote recovery.
Thorough documentation of substance use history, withdrawal symptoms, and treatment plans.
Patients presenting with acute withdrawal symptoms, requiring detoxification and stabilization.
Consideration of co-occurring mental health disorders and the need for integrated treatment approaches.
Detailed mental status examinations and assessments of substance use impact on mental health.
Patients with a history of anxiety or sleep disorders exacerbated by substance use.
Monitoring for potential interactions between prescribed psychiatric medications and substances of abuse.
Used during initial evaluation of a patient presenting with withdrawal symptoms.
Comprehensive assessment notes detailing the patient's history and current symptoms.
Addiction specialists should focus on substance use history and mental health status.
Key symptoms include confusion, agitation, hallucinations, tremors, and autonomic instability such as sweating and increased heart rate.
